The metabolic syndrome (Emperor) wears no clothes

Diabetes Care

Volumn 29, Issue 7, 2006, Pages 1693-1696

  Kahn, Richard ^a  

^a AMERICAN DIABETES ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; METABOLIC SYNDROME X; NOTE; RISK ASSESSMENT;

EID: 33746453341     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0671     Document Type: Note

References (31)

1. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304, 2005
2. Service FJ: Mechanisms of metabolic mischief: meritorious or meretricious? Endocr Pract 9:101-102, 2003
3. Reaven GM: The metabolic syndrome: requiescat in pace. Clin Chem 51:931-938, 2005
4. Gale EA: The myth of the metabolic syndrome. Diabetologia 48:1679-1683, 2005
5. Kohli P, Greenland P: Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA 295:819-821, 2006
6. Greenland P: Critical questions about the metabolic syndrome. Circulation 112: 3675-3676, 2005
7. Grundy SM: Does the metabolic syndrome exist? Diabetes Care 29:1689-1692, 2006
8. Grundy SM: Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093-1100, 2006
9. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438, 2004
10. Grundy SM, Cleeman JI, Rifkind BM, Kuller LH: Cholesterol lowering in the elderly population: Coordinating Committee of the National Cholesterol Education Program. Arch Intern Med 159:1670-1678, 1999
11. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome: a new worldwide definition. Lancet 366:1059-1062, 2005
12. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
13. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES: Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53:1195-1200, 2004
14. Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT: Critical evaluation of Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 27:978-983, 2004
15. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G: Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139:802-809, 2003
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
17. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644-2650, 2005
18. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 26:3153-3159, 2003
19. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB Jr, Wagenknecht LE, Haffner SM: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 112:3713-3721, 2005
20. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066-3072, 2005
21. Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundstrom J, Kannel WB, Levy D, D'Agostino RB: Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 142:393-402, 2005
22. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366:1640-1649, 2005
23. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F: Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the Atherosclerosis Risk in Communities study. Diabetes 51:3069-3076, 2002
24. Yarnell JW, Patterson CC, Bainton D, Sweetnam PM: Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies. Heart 79:248-252, 1998
25. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28:385-390, 2005
26. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414-419, 2003
27. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210-1214, 2003
28. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, Kuller LH: Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 29:123-130, 2006
29. Sundström J, Vallhagen E, Risérus U, Byberg L, Zethelius B, Berne C, Lind L, Ingelsson E: Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 29:1673-1674, 2006
30. Mitka M: Biomarkers for coronary heart disease: predictive value or background noise? JAMA 292:2824-2825, 2004
31. University of Michigan: The MET FIT program: treating the metabolic syndrome by improving metabolic fitness [article online], 2005. Available at http://www.med.umich.edu/cvc%20/adult/metfit.htm. Accessed 24 March 2006